These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 33463748)

  • 1. Sample size calculation for cluster randomization trials with a time-to-event endpoint.
    Li J; Jung SH
    Stat Med; 2020 Nov; 39(25):3608-3623. PubMed ID: 33463748
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sample size calculation for clustered survival data under subunit randomization.
    Li J; Jung SH
    Lifetime Data Anal; 2022 Jan; 28(1):40-67. PubMed ID: 34716530
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sample size calculation for weighted rank tests comparing survival distributions under cluster randomization: a simulation method.
    Jung SH
    J Biopharm Stat; 2007; 17(5):839-49. PubMed ID: 17885869
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sample size estimation for stratified cluster randomization trial with survival endpoint.
    Ni S; Zhong Z; Zhao Y; Chen F; Wu J; Yu H; Bai J
    Stat Methods Med Res; 2024 May; 33(5):838-857. PubMed ID: 38549457
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Group sequential testing for cluster randomized trials with time-to-event endpoint.
    Li J; Jung SH
    Biometrics; 2022 Dec; 78(4):1353-1364. PubMed ID: 34076257
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Power and sample size calculations for cluster randomized trials with binary outcomes when intracluster correlation coefficients vary by treatment arm.
    Kennedy-Shaffer L; Hughes MD
    Clin Trials; 2022 Feb; 19(1):42-51. PubMed ID: 34879711
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Design and analysis of cluster randomized trials with time-to-event outcomes under the additive hazards mixed model.
    Blaha O; Esserman D; Li F
    Stat Med; 2022 Oct; 41(24):4860-4885. PubMed ID: 35908796
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The optimal design of stepped wedge trials with equal allocation to sequences and a comparison to other trial designs.
    Thompson JA; Fielding K; Hargreaves J; Copas A
    Clin Trials; 2017 Dec; 14(6):639-647. PubMed ID: 28797179
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sample size considerations for matched-pair cluster randomization design with incomplete observations of continuous outcomes.
    Xu X; Zhu H; Ahn C
    Contemp Clin Trials; 2021 May; 104():106336. PubMed ID: 33689919
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A flexible sample size solution for longitudinal and crossover cluster randomized trials with continuous outcomes.
    Wang J; Cao J; Zhang S; Ahn C
    Contemp Clin Trials; 2021 Oct; 109():106543. PubMed ID: 34450326
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Incorporating pragmatic features into power analysis for cluster randomized trials with a count outcome.
    Li D; Zhang S; Cao J
    Stat Med; 2020 Nov; 39(27):4037-4050. PubMed ID: 33165949
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Randomization-based inference for a marginal treatment effect in stepped wedge cluster randomized trials.
    Rabideau DJ; Wang R
    Stat Med; 2021 Sep; 40(20):4442-4456. PubMed ID: 34018624
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Accounting for expected attrition in the planning of cluster randomized trials for assessing treatment effect heterogeneity.
    Tong J; Li F; Harhay MO; Tong G
    BMC Med Res Methodol; 2023 Apr; 23(1):85. PubMed ID: 37024809
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sample size considerations for stratified cluster randomization design with binary outcomes and varying cluster size.
    Xu X; Zhu H; Ahn C
    Stat Med; 2019 Aug; 38(18):3395-3404. PubMed ID: 31033011
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sample size determination for three-level randomized clinical trials with randomization at the first or second level.
    Fazzari MJ; Kim MY; Heo M
    J Biopharm Stat; 2014; 24(3):579-99. PubMed ID: 24697506
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A readily available improvement over method of moments for intra-cluster correlation estimation in the context of cluster randomized trials and fitting a GEE-type marginal model for binary outcomes.
    Westgate PM
    Clin Trials; 2019 Feb; 16(1):41-51. PubMed ID: 30295512
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sample size considerations for assessing treatment effect heterogeneity in randomized trials with heterogeneous intracluster correlations and variances.
    Tong G; Taljaard M; Li F
    Stat Med; 2023 Aug; 42(19):3392-3412. PubMed ID: 37316956
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sample size considerations for matched-pair cluster randomization design with incomplete observations of binary outcomes.
    Xu X; Zhu H; Hoang AQ; Ahn C
    Stat Med; 2021 Oct; 40(24):5397-5416. PubMed ID: 34245031
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The impact of varying cluster size in cross-sectional stepped-wedge cluster randomised trials.
    Martin JT; Hemming K; Girling A
    BMC Med Res Methodol; 2019 Jun; 19(1):123. PubMed ID: 31200640
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sample size calculation for cluster randomized trials with zero-inflated count outcomes.
    Zhou Z; Li D; Zhang S
    Stat Med; 2022 May; 41(12):2191-2204. PubMed ID: 35139584
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.